Please login to the form below

Not currently logged in
Email:
Password:

Icon boost medical device trial capability with Aptiv acquisition

Deal will also enhance the CRO's position inadaptive trials and in Japan

Dublin-based contract research organisation Icon has acquired Aptiv Solutions for $143.5m, boosts its capabilities to run adapative and medical device trials.  

The deal will also expand Icon's footprint in Japan, allowing it to combine its existing operations in Tokyo and Osaka with Niphix, a full-service oncology-focused CRO owned by Aptiv.  

Dr Nuala Murphy, president of Icon Clinical Research Services, said: “Icon's market-leading innovation is helping our customers to reduce the time and cost of drug development.  

“Aptiv Solutions' adaptive trial capabilities will further differentiate and enhance our services to help our customers identify the most promising drug candidates earlier. Their presence in Japan will also broaden our existing capabilities in this market.”  

Icon's acquisition of Aptiv comes some six weeks after the US-headquartered CRO teamed up with Novartis, Janssen and Lilly to form a consortium to work on adaptive dose finding trials.  

The ADDPLAN DF Consortium partners will collaborate on developing new statistical methodologies for the design of innovative dose-finding clinical trials, with an emphasis on adaptive designs.  

It's an area European regulators are planning to look at in more details soon, when they launch an adaptive licensing pilot.

Article by
Dominic Tyer

2nd April 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics